Physician profile
Andre H Bruni
NPI 1639381890
$6,555.82
in general payments reported to CMS, 2019-2025
13 companies · $3,948 in 2025
The $3,948 reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $10.08 · 2021: $1,023 · 2022: $531 · 2023: $748 · 2024: $33.94 · 2025: $3,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $3,931 · Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $3,931.40 |
| Food and Beverage | $798.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $4,625.15 | 2021-2025 | |
| Align Technology, INC. | $429.78 | 2019-2025 | Invisalign, Itero Element 5d Plus, Invisalign Go |
| Straumann USA LLC | $412.67 | 2021-2025 | |
| Ultradent Products INC | $360.28 | 2022-2024 | |
| Kerr Corporation | $267.95 | 2021-2023 | Endodontics, Harmonize |
| Lumenis Be INC | $128.48 | 2023 | M22 |
| Dentsply Sirona INC | $109.68 | 2019-2021 | |
| Nobel Biocare USA | $76.86 | 2023 | Nobelactive |
| Envista Holdings Corporation | $53.22 | 2025 | Maxcem Elite |
| Implant Direct Sybron International LLC | $49.03 | 2019 | |
| Coltene Whaledent INC. | $16.97 | 2019 | |
| Solventum Corporation | $14.28 | 2025 | 3m Scotchbond, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Relyx |
| Voco America INC. | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Bruni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.